Table 1 Baseline demographics and laboratory characteristics.

From: Point of Care eGFR and the Prediction of Outcomes in Pneumonia

Characteristics

Total

Non-CKD

CKD

p value

Number

1554

1291

263

N/A

Age

76.1 ± 16.7

75.1 ± 17.3

81.1 ± 12.1

<0.01

Male

987 (63.5%)

781 (60.5%)

206 (78.3%)

<0.01

CAD

60 (3.9%)

45 (3.5%)

15 (5.7%)

0.09

COPD

102 (6.6%)

90 (7.0%)

12 (4.6%)

0.15

DM

110 (7.1%)

80 (6.2%)

30 (11.4%)

<0.01

Hb (g/dL)

11.8 ± 2.2

12.1 ± 2.1

10.4 ± 2.1

<0.01

Albumin (g/dL)

2.9 ± 0.6

2.9 ± 0.6

2.9 ± 0.6

0.21

BUN (mg/dL)

20 (13, 32)

18 (12, 26)

42 (27, 61)

<0.01a

Creatinine (mg/dL)

0.9 (0.7, 1.4)

0.9 (0.7, 1.1)

2.2 (1.6, 4.4)

<0.01a

eGFR (mL/min/1.73 m2)

78.9 (48.6, 115.0)

89.4 (63.5, 124.1)

25.7 (5.0, 40.4)

<0.01a

CRP (mg/dL)

7.6 (2.8, 14.4)

7.3 (2.5, 13.8)

9.3 (4.5, 16.7)

<0.01a

AST (U/mL)

25 (19, 35)

25 (19, 34)

26 (19, 36)

0.17a

ALT (U/mL)

19 (13, 29)

19 (13, 29)

17.5 (12, 27)

0.11a

Na (mmol/L)

134.2 ± 7.1

134.0 ± 7.1

135.0 ± 7.0

0.04

K (mmol/L)

4.1 ± 0.7

4.0 ± 0.6

4.3 ± 0.8

<0.01

  1. CKD, chronic kidney disease; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; Hb, hemoglobin; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; CRP, C-reactive protein; AST, aspartate transaminase; ALT, alanine transaminase.
  2. aCompared by Exact Wilcoxon two-sample test.